30 results
Page 2 of 2
8-K
EX-99.1
ocfm jcbm7jknpb
10 Nov 21
Equillium Reports Third Quarter 2021 Financial Results and Provides Clinical Development Updates
4:05pm
8-K
tzxtqwx91111 0bob
10 Jun 21
Regulation FD Disclosure
11:13am
8-K
EX-99.1
nl1fj
10 Jun 21
Regulation FD Disclosure
11:13am
8-K
EX-99.1
xtt eqyfv
13 May 21
Equillium Reports First Quarter 2021 Financial Results and Provides Clinical Development Update
4:13pm
8-K
EX-99.1
xzl dabayd
24 Mar 21
Equillium Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development Update
4:10pm
8-K
EX-99.1
mbrc4tmmy325
15 Mar 21
Regulation FD Disclosure
8:02am
8-K
hscjrkw829gsxm
15 Mar 21
Regulation FD Disclosure
8:02am
8-K
EX-99.1
pq6c4fe1db xmdevtbm4
7 Dec 20
Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell
9:24am
8-K
8e4u813yzb813f0q
7 Dec 20
Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell
9:24am
8-K
EX-99.1
jcbvyty
10 Nov 20
Equillium Reports Third Quarter 2020 Financial Results and Business Highlights
4:11pm